The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Adenosine-to-inosine RNA editing and human disease
Open accessAbstract
A-to-I RNA editing is a post-transcriptional modification that converts adenosines to inosines in both coding and noncoding RNA transcripts. It is catalyzed by ADAR (adenosine deaminase acting on RNA) enzymes, which exist throughout the body but are most prevalent in the central nervous system. Inosines exhibit properties that are most similar to those of guanosines. As a result, ADAR-mediated editing can post-transcriptionally alter codons, introduce or remove splice sites, or affect the base pairing of the RNA molecule with itself or with other RNAs. A-to-I editing is a mechanism that regulates and diversifies the transcriptome, but the full biological significance of ADARs is not understood. ADARs are highly conserved across vertebrates and are essential for normal development in mammals. Aberrant ADAR activity has been associated with a wide range of human diseases, including cancer, neurological disorders, metabolic diseases, viral infections and autoimmune disorders. ADARs have been shown to contribute to disease pathologies by editing of glutamate receptors, editing of serotonin receptors, mutations in ADAR genes, and by other mechanisms, including recently identified regulatory roles in microRNA processing. Advances in research into many of these diseases may depend on an improved understanding of the biological functions of ADARs. Here, we review recent studies investigating connections between ADAR-mediated RNA editing and human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
MicroRNAs in Stress Signaling and Human Disease
Mendell, J. T., & Olson, E. N. (2012) · Cell · doi:10.1016/j.cell.2012.02.005 · Cited by 1,673
RNA editing in brain controls a determinant of ion flow in glutamate-gated channels
Sommer, B., Köhler, M., Sprengel, R., & Seeburg, P. H. (1991) · Cell · doi:10.1016/0092-8674(91)90568-j · Cited by 1,517
Ca2 + Permeability of KA-AMPA—Gated Glutamate Receptor Channels Depends on Subunit Composition
Hollmann, M., Hartley, M., & Heinemann, S. (1991) · Science · doi:10.1126/science.1709304 · Cited by 1,456
Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding
Helwak, A., Kudla, G., Dudnakova, T., & Tollervey, D. (2013) · Cell · doi:10.1016/j.cell.2013.03.043 · Cited by 1,269
Neurobiology of suicidal behaviour
Mann, J. J. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1220 · Cited by 1,260
Functions and Regulation of RNA Editing by ADAR Deaminases
Nishikura, K. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060208-105251 · Cited by 1,242
Self-citationRegulation of serotonin-2C receptor G-protein coupling by RNA editing
Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E., & Emeson, R. B. (1997) · Nature · doi:10.1038/387303a0 · Cited by 1,010 · cited 1×
“Editing of 5-HT2CR significantly reduces serotonin potency and G-protein coupling, demonstrating a level of regulation of receptor sensitivity [39-41].”
BackgroundHiguchi, M., Maas, S., Single, F. N., Hartner, J., Rozov, A., Burnashev, N., Feldmeyer, D., Sprengel, R., & Seeburg, P. H. (2000) · Nature · doi:10.1038/35017558 · Cited by 967
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Crow, Y. J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black, D. N., van Bokhoven, H., Brunner, H. G., Hamel, B. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1845 · Cited by 903
Diabetes Mellitus and the β Cell: The Last Ten Years
Ashcroft, F. M., & Rorsman, P. (2012) · Cell · doi:10.1016/j.cell.2012.02.010 · Cited by 902
Widespread A-to-I RNA Editing of Alu-Containing mRNAs in the Human Transcriptome
Athanasiadis, A., Rich, A., & Maas, S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020391 · Cited by 740
Redirection of Silencing Targets by Adenosine-to-Inosine Editing of miRNAs
Kawahara, Y., Zinshteyn, B., Sethupathy, P., Iizasa, H., Hatzigeorgiou, A. G., & Nishikura, K. (2007) · Science · doi:10.1126/science.1138050 · Cited by 712
Self-citationCurrent hypotheses for the underlying biology of amyotrophic lateral sclerosis
Rothstein, J. D. (2009) · Annals of Neurology · doi:10.1002/ana.21543 · Cited by 703
Rice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.373 · Cited by 689
Crow, Y. J., Leitch, A., Hayward, B. E., Garner, A., Parmar, R., Griffith, E., Ali, M., Semple, C., Aicardi, J., Babul-Hirji, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1842 · Cited by 675
Brusa, R., Zimmermann, F., Koh, D.-S., Feldmeyer, D., Gass, P., Seeburg, P. H., & Sprengel, R. (1995) · Science · doi:10.1126/science.270.5242.1677 · Cited by 592
Patterson, J. B., & Samuel, C. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5376 · Cited by 576
Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma
Chen, L., Li, Y., Lin, C. H., Chan, T. H. M., Chow, R. K. K., Song, Y., Liu, M., Yuan, Y.-F., Fu, L., Kong, K. L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3043 · Cited by 517
Liver Disintegration in the Mouse Embryo Caused by Deficiency in the RNA-editing Enzyme ADAR1
Hartner, J. C., Schmittwolf, C., Kispert, A., Müller, A. M., Higuchi, M., & Seeburg, P. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311347200 · Cited by 506
Stress-induced Apoptosis Associated with Null Mutation of ADAR1 RNA Editing Deaminase Gene
Wang, Q., Miyakoda, M., Yang, W., Khillan, J., Stachura, D. L., Weiss, M. J., & Nishikura, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310162200 · Cited by 501
Self-citationADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling
Hartner, J. C., Walkley, C. R., Lu, J., & Orkin, S. H. (2009) · Nature Immunology · doi:10.1038/ni.1680 · Cited by 490
Cattaneo, R., Schmid, A., Eschle, D., Baczko, K., ter Meulen, V., & Billeter, M. A. (1988) · Cell · doi:10.1016/0092-8674(88)90048-7 · Cited by 434
Underediting of glutamate receptor GluR-B mRNA in malignant gliomas
Maas, S., Patt, S., Schrey, M., & Rich, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251531398 · Cited by 382
Palladino, M. J., Keegan, L. P., O'Connell, M. A., & Reenan, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00049-0 · Cited by 380
Gurevich, I., Tamir, H., Arango, V., Dwork, A. J., Mann, J. J., & Schmauss, C. (2002) · Neuron · doi:10.1016/s0896-6273(02)00660-8 · Cited by 377
RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity
Niswender, C. M., Copeland, S. C., Herrick-Davis, K., Emeson, R. B., & Sanders-Bush, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9472 · Cited by 363
ADAR1 Forms a Complex with Dicer to Promote MicroRNA Processing and RNA-Induced Gene Silencing
Ota, H., Sakurai, M., Gupta, R., Valente, L., Wulff, B.-E., Ariyoshi, K., Iizasa, H., Davuluri, R. V., & Nishikura, K. (2013) · Cell · doi:10.1016/j.cell.2013.03.024 · Cited by 360
Self-citationAltered adenosine-to-inosine RNA editing in human cancer
Paz, N., Levanon, E. Y., Amariglio, N., Heimberger, A. B., Ram, Z., Constantini, S., Barbash, Z. S., Adamsky, K., Safran, M., Hirschberg, A., et al. (2007) · Genome Research · doi:10.1101/gr.6493107 · Cited by 346
Savva, Y. A., Rieder, L. E., & Reenan, R. A. (2012) · Genome Biology · doi:10.1186/gb-2012-13-12-252 · Cited by 341
RNA editing of human microRNAs
Blow, M. J., Grocock, R. J., van Dongen, S., Enright, A. J., Dicks, E., Futreal, P. A., Wooster, R., & Stratton, M. R. (2006) · Genome Biology · doi:10.1186/gb-2006-7-4-r27 · Cited by 338
Frequency and fate of microRNA editing in human brain
Kawahara, Y., Megraw, M., Kreider, E., Iizasa, H., Valente, L., Hatzigeorgiou, A. G., & Nishikura, K. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn479 · Cited by 325
Self-citationAdenosine deaminases acting on RNA (ADARs) are both antiviral and proviral
Samuel, C. E. (2011) · Virology · doi:10.1016/j.virol.2010.12.004 · Cited by 315
RED2, a Brain-specific Member of the RNA-specific Adenosine Deaminase Family
Melcher, T., Maas, S., Herb, A., Sprengel, R., Higuchi, M., & Seeburg, P. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31795 · Cited by 295
Large-scale mRNA sequencing determines global regulation of RNA editing during brain development
Wahlstedt, H., Daniel, C., Ensterö, M., & Öhman, M. (2009) · Genome Research · doi:10.1101/gr.089409.108 · Cited by 287
A-to-I RNA Editing and Human Disease
Maas, S., Kawahara, Y., Tamburro, K. M., & Nishikura, K. (2006) · RNA Biology · doi:10.4161/rna.3.1.2495 · Cited by 262
Self-citationMiyamura, Y., Suzuki, T., Kono, M., Inagaki, K., Ito, S., Suzuki, N., & Tomita, Y. (2003) · The American Journal of Human Genetics · doi:10.1086/378209 · Cited by 260
Niswender, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00223-2 · Cited by 256
Prader-Willi Syndrome: Obesity due to Genomic Imprinting
G. Butler, M. (2011) · Current Genomics · doi:10.2174/138920211795677877 · Cited by 239
Peng, P. L., Zhong, X., Tu, W., Soundarapandian, M. M., Molner, P., Zhu, D., Lau, L., Liu, S., Liu, F., & Lu, Y. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.025 · Cited by 230
Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis
Kwak, S., & Kawahara, Y. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0599-z · Cited by 215
The essential role of AMPA receptor GluR2 subunit RNA editing in the normal and diseased brain
Wright, A., & Vissel, B. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00034 · Cited by 212
Liu, S., Lau, L., Wei, J., Zhu, D., Zou, S., Sun, H.-S., Fu, Y., Liu, F., & Lu, Y. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.017 · Cited by 208
Optimal role of temozolomide in the treatment of malignant gliomas
Stupp, R., van den Bent, M. J., & Hegi, M. E. (2005) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-005-0047-7 · Cited by 208
Requirement of Dimerization for RNA Editing Activity of Adenosine Deaminases Acting on RNA
Cho, D.-S. C., Yang, W., Lee, J. T., Shiekhattar, R., Murray, J. M., & Nishikura, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213127200 · Cited by 195
Self-citationCa2+-Permeable AMPA Receptors Regulate Growth of Human Glioblastoma via Akt Activation
Ishiuchi, S., Yoshida, Y., Sugawara, K., Aihara, M., Ohtani, T., Watanabe, T., Saito, N., Tsuzuki, K., Okado, H., Miwa, A., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2180-07.2007 · Cited by 194
ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia
Jiang, Q., Crews, L. A., Barrett, C. L., Chun, H.-J., Court, A. C., Isquith, J. M., Zipeto, M. A., Goff, D. J., Minden, M., Sadarangani, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213021110 · Cited by 190
Down-regulation of RNA Editing in Pediatric Astrocytomas
Cenci, C., Barzotti, R., Galeano, F., Corbelli, S., Rota, R., Massimi, L., Di Rocco, C., O'Connell, M. A., & Gallo, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708316200 · Cited by 190
Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons
Hideyama, T., Yamashita, T., Aizawa, H., Tsuji, S., Kakita, A., Takahashi, H., & Kwak, S. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.033 · Cited by 188
A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology
Yamashita, T., Hideyama, T., Hachiga, K., Teramoto, S., Takano, J., Iwata, N., Saido, T. C., & Kwak, S. (2012) · Nature Communications · doi:10.1038/ncomms2303 · Cited by 179
Contributions of 5-HT2C receptors to multiple actions of central serotonin systems
Giorgetti, M., & Tecott, L. H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.01.036 · Cited by 173
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth
Nemlich, Y., Greenberg, E., Ortenberg, R., Besser, M. J., Barshack, I., Jacob-Hirsch, J., Jacoby, E., Eyal, E., Rivkin, L., Prieto, V. G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62980 · Cited by 167
Bass, B. L., Weintraub, H., Cattaneo, R., & Billeter, M. A. (1989) · Cell · doi:10.1016/0092-8674(89)90234-1 · Cited by 162
Induced Loss of ADAR2 Engenders Slow Death of Motor Neurons from Q/R Site-Unedited GluR2
Hideyama, T., Yamashita, T., Suzuki, T., Tsuji, S., Higuchi, M., Seeburg, P. H., Takahashi, R., Misawa, H., & Kwak, S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2021-10.2010 · Cited by 158
Valente, L., & Nishikura, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611392200 · Cited by 153
Self-citationGaleano, F., Rossetti, C., Tomaselli, S., Cifaldi, L., Lezzerini, M., Pezzullo, M., Boldrini, R., Massimi, L., Rocco, C. M. D., Locatelli, F., et al. (2012) · Oncogene · doi:10.1038/onc.2012.125 · Cited by 152
Toth, A. M., Li, Z., Cattaneo, R., & Samuel, C. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045146 · Cited by 151
Kawahara, Y., Kwak, S., Sun, H., Ito, K., Hashida, H., Aizawa, H., Jeong, S., & Kanazawa, I. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01703.x · Cited by 129
Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader–Willi syndrome
Morabito, M. V., Abbas, A. I., Hood, J. L., Kesterson, R. A., Jacobs, M. M., Kump, D. S., Hachey, D. L., Roth, B. L., & Emeson, R. B. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.004 · Cited by 127
RNA Editing of the Human Serotonin 5-HT2CReceptor Alters Receptor-mediated Activation of G13Protein
Price, R. D., Weiner, D. M., Chang, M., & Sanders‐Bush, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106745200 · Cited by 112
Kawahara, Y., Grimberg, A., Teegarden, S., Mombereau, C., Liu, S., Bale, T. L., Blendy, J. A., & Nishikura, K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3896-08.2008 · Cited by 105
Self-citationA-to-I RNA editing: the "ADAR" side of human cancer.
Galeano, F., Tomaselli, S., Locatelli, F., & Gallo, A. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.09.003 · Cited by 102
ADARs: Viruses and Innate Immunity
Samuel, C. E. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_148 · Cited by 101
Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide
Dracheva, S. M., Patel, N., Woo, D. A., Marcus, S., Siever, L. J., & Haroutunian, V. H. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002081 · Cited by 98
Gélinas, J., Clerzius, G., Shaw, E., & Gatignol, A. (2011) · Journal of Virology · doi:10.1128/jvi.00240-11 · Cited by 95
Tariq, A., Garncarz, W., Handl, C., Balík, A., Pusch, O., & Jantsch, M. F. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1353 · Cited by 88
Tariq, A., & Jantsch, M. F. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00099 · Cited by 88
AMPA receptor-mediated neuronal death in sporadic ALS
Kwak, S., Hideyama, T., Yamashita, T., & Aizawa, H. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2009.01090.x · Cited by 87
Mutations and A/I Hypermutations in Measles Virus Persistent Infections
Cattaneo, R., & Billeter, M. A. (1992) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-77011-1_5 · Cited by 85
Genetic Diversity of RNA Viruses
Holland, J. J. (1992) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-77011-1 · Cited by 84
Comparative RNA editing in autistic and neurotypical cerebella
Eran, A., Li, J. B., Vatalaro, K., McCarthy, J., Rahimov, F., Collins, C., Markianos, K., Margulies, D. M., Brown, E. N., Calvo, S. E., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.118 · Cited by 70
Gallo, A., & Locatelli, F. (2011) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2011.00186.x · Cited by 69
Editing of Neurotransmitter Receptor and Ion Channel RNAs in the Nervous System
Hood, J. L., & Emeson, R. B. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_157 · Cited by 68
RNA Editing by ADAR2 Is Metabolically Regulated in Pancreatic Islets and β-Cells
Gan, Z., Zhao, L., Yang, L., Huang, P., Zhao, F., Li, W., & Liu, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604484200 · Cited by 67
García-López, J., Hourcade, J. D. D., & del Mazo, J. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt247 · Cited by 56
Comparative analysis of the DRADA A-to-I RNA editing gene from mammals, pufferfish and zebrafish
Slavov, D. B., Crnogorac‐Jurcevic, T., Clark, M. S., & Gardiner, K. (2000) · Gene · doi:10.1016/s0378-1119(00)00175-x · Cited by 42
Kung, S.-S., Chen, Y., Lin, W., Chen, C.-C., & Chow, W. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03183-0 · Cited by 35
Quantitative analysis of 5HT2C receptor RNA editing patterns in psychiatric disorders
O’Neil, R. T., & Emeson, R. B. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.026 · Cited by 35
Deficiency in RNA editing enzyme ADAR2 impairs regulated exocytosis
Liu, Y., Zhao, L., Gan, Z., He, Z., Xu, J., Gao, X., Wang, X., Han, W., Chen, L., Xu, T., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-152363 · Cited by 27
Comparative RNA editing in autistic and neurotypical cerebella.
Eran, A., & Kunkel, L. M. (2013) · doi:10.15154/1163546 · Cited by 23
Cited by
A-to-I editing of coding and non-coding RNAs by ADARs
Nishikura, K. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.4 · Cited by 1,041
Self-citationEpigenetic regulation of aging: implications for interventions of aging and diseases
Wang, K., Liu, H., Hu, Q., Wang, L., Liu, J., Zheng, Z., Zhang, W., Ren, J., Zhu, F., & Liu, G.-H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01211-8 · Cited by 663
Cellular origins of dsRNA, their recognition and consequences
Chen, Y. G., & Hur, S. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00430-1 · Cited by 433
Retrotransposons as regulators of gene expression
Elbarbary, R. A., Lucas, B. A., & Maquat, L. E. (2016) · Science · doi:10.1126/science.aac7247 · Cited by 428
Double-Stranded RNA Sensors and Modulators in Innate Immunity
Hur, S. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041356 · Cited by 420
Metadata
- Authors
- Slotkin, W., & Nishikura, K.
- Venue
- Genome Medicine
- Published
- 2013
- Volume
- 5
- Issue
- 11
- Pages
- 105
- ISSN
- 1756-994X (ISSN-L)
- OpenAlex
- W1978974023
- Cited by
- 296
- References
- 82
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.